Background: Cerebral thromboembolic complications remain one of the most severe complications of catheter ablation of atrial ibrillation (AF). However, due to different ablation approaches, energy sources and peri-interventional management there is inconsistent data on incidence, characteristics and outcome...
eiden mutation and the risks for thromboembolic disease: a clinical perspective. Ann Intern Med, 127 (1997), pp. 895-903 CrossrefView in ScopusGoogle Scholar 49 M Den Heijer, FR Rosendaal, HJ Blom, WB Gerrits, GM Bos Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemo...
Department of Clinical Medicine, Research Center on Thromboembolic Disorders and Antithrombotic Therapies, University of Insubria, Varese, Italy Francesco Dentali & Walter Ageno U.O. Medicina I, Ospedale di Circolo, Viale Borri 57, 21100, Varese, Italy Walter Ageno Corresponding author Cite this arti...
De Herdt, V.et al. Early seizures in intracerebral hemorrhage: incidence, associated factors, and outcome.Neurology77, 1794–1800 (2011). ArticleCASGoogle Scholar Ferro, J. M.et al. Early seizures in cerebral vein and dural sinus thrombosis: risk factors and role of antiepileptics.Stroke39, ...
1996: Influence of clinical presentation, vascular risk factors and therapy on survival and risk of thromboembolic complications in 141 patients with essential thrombocythemia Annals of Hematology 73(Suppl 2): A97 Jantunen, R.; Juvonen, E.; Ikkala, E.; Oksanen, K.; Anttila, P.; Ruutu, ...
Direct oral anticoagulants (DOACs) have already established benefit over warfarin as a long-term treatment of symptomatic venous thromboembolic disorder like deep vein thrombosis (DVT), and pulmonary embolism (PE) given its equal efficacy and better safety profile. The benefit of DOACs over warfarin ...
Stroke is the second leading cause of death and disability worldwide and mostly caused by thromboembolic occlusion of major brain vessels. In human stroke the middle cerebral artery (MCA) and its branches are most commonly affected and account for approximately 70% of infarcts1. There are several...
Venous thromboembolic events after cerebral vein thrombosis. Stroke. 2010;41(9):1901-1906. doi:10.1161/STROKEAHA.110.581223PubMedGoogle ScholarCrossref 6. Martinelli I, Bucciarelli P, Passamonti SM, Battaglioli T, Previtali E, Mannucci PM. Long-term evaluation of the risk of recurrence after...
Patients with cancer are prone to develop systemic thromboembolic complications, and prophylactic methods have been established to prevent deep vein thrombosis, pulmonary embolism, and thrombosis of indwelling venous catheters for chemotherapy administration in high-risk patients. These methods include intermit...
Treatment of this disease includes addressing the acutethrombus; addressing the symptoms caused by the thrombus, such as headache, nausea, andseizures; identification of the factors that placed patients at risk of thrombus development; and optimizing therapy to prevent future thromboembolic events. Antico...